ENOV news

Enovis increased its full-year 2026 adjusted EBITDA and EPS guidance while narrowing revenue targets. The company also secured a $200 million share repurchase authorization.

Enovis Corp entered a binding offer to acquire eCential Robotics for €155 million in cash and potential earnouts to bolster its surgical robotics capabilities. The deal will be funded through cash and a revolving credit facility.

Enovis reported Q2 net sales of $583 million, adjusted EPS of $0.90, and reaffirmed full-year 2026 revenue and adjusted EBITDA guidance, citing continued commercial execution.

Enovis filed a third amendment to its 2020 Omnibus Incentive Plan requesting shareholder approval to increase available shares from approximately 4.3M to 7.97M, effective pending a May 2026 annual meeting vote. The company also raised the annual compensation cap for outside directors from $350,000 t…